Key result
The PKP2 splice site mutation c.2489+4A>C leads to aberrant mRNA and a wide range of disease severity in carriers, demonstrating variable expression and incomplete penetrance in ARVD/C.
Observational
A founder splice site mutation in PKP2 causes ARVD/C with highly variable expression and incomplete penetrance, suggesting additional factors are required for disease manifestation.
Answers are grounded in this paper and cite their sources.
Supports cautious genetic counseling for ARVD/C families given incomplete penetrance; leaves open identification of disease modifiers in PKP2 carriers.
OBJECTIVES: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is characterized by fibrofatty replacement of cardiomyocytes. In around 50% of index patients, a genetic predisposition is demonstrated. The purpose of this study was to examine a plakophilin-2 (PKP2) splice site mutation, c.2489+4A>C, identified in 4 separately ascertained Dutch ARVD/C families. METHODS: Genealogical studies and comprehensive screening of 5 desmosomal genes were undertaken. Reverse transcriptase PCR (RT-PCR) and subsequent sequencing was performed. RESULTS: An A-to-C change (c.2489+4A>C) near the splice donor site of intervening sequence 12 of PKP2 was found in all 4 families. Based on pedigree data and haplotype sharing, a common ancestor should be situated more than 7 generations ago. RT-PCR demonstrated the presence of aberrant messenger RNA. Clinical manifestations ranged from severe disease to nonpenetrance in elderly mutation carriers. CONCLUSIONS: This founder mutation in PKP2 is predicted to lead to the presence of a dysfunctional PKP2 protein, whereas most truncating mutations are expected to lead to loss of protein. Mutation carriers displayed a wide range of disease severity, suggesting that PKP2 mutations alone are not sufficient to cause disease, which results in the variable expression and incomplete penetrance characteristic of ARVD/C mutations.
No takes yet. Share an insight, caveat, or question.
Smagt et al. (2012) conducted an observational in Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). plakophilin-2 (PKP2) splice site mutation, c.2489+4A>C was evaluated on Presence of aberrant messenger RNA and clinical manifestations. The PKP2 splice site mutation c.2489+4A>C leads to aberrant mRNA and a wide range of disease severity in carriers, demonstrating variable expression and incomplete penetrance in ARVD/C.
Synapse has enriched 10 related papers. Consider them for comparative context: